ライフサイエンスコーパス: broad-spectrum antibiotic

1 a(-/-)PI2(-/-) NOD mice with enrofloxacin, a broad-spectrum antibiotic.

2 polymerase (RNAP) is a validated target for broad spectrum antibiotics.

3 diduria in critically ill children receiving broad spectrum antibiotics.

4 aneous flap reconstruction along with use of broad spectrum antibiotics.

5 FNgamma and were prevented by treatment with broad spectrum antibiotics.

6 bers, and was not affected by treatment with broad-spectrum antibiotics.

7 robiome has been perturbed by treatment with broad-spectrum antibiotics.

8 cated when the organism becomes resistant to broad-spectrum antibiotics.

9 ngal infections by producing peptide-derived broad-spectrum antibiotics.

10 in older (>/=65 years) inpatients exposed to broad-spectrum antibiotics.

11 ppression of intestinal microbiota with oral broad-spectrum antibiotics.

12 e and compared the effects of treatment with broad-spectrum antibiotics.

13 ad to fewer patients unnecessarily receiving broad-spectrum antibiotics.

14 prevent infections in patients treated with broad-spectrum antibiotics.

15 growth in broth and may provide a basis for broad-spectrum antibiotics.

16 to expand our currently available arsenal of broad-spectrum antibiotics.

17 despread use of immunosuppressive agents and broad-spectrum antibiotics.

18 environment and is prevented and treated by broad-spectrum antibiotics.

19 lead to the development of a novel class of broad-spectrum antibiotics.

20 ituberculosis treatment, he was treated with broad-spectrum antibiotics.

21 igases as targets for the development of new broad-spectrum antibiotics.

22 not experience neutropenic fevers or require broad-spectrum antibiotics.

23 which makes them attractive targets for new broad-spectrum antibiotics.

24 early and repeated extensive debridement and broad-spectrum antibiotics.

25 Ds per 1000 patient-days per month for other broad-spectrum antibiotics.

26 Ds per 1000 patient-days per month for other broad-spectrum antibiotics.

27 se with high BSI risk (> 40%) be admitted on broad-spectrum antibiotics.

28 t colonizes the gut of patients treated with broad-spectrum antibiotics.

29 ampylobacterales, which can be reversed with broad-spectrum antibiotics.

30 ich was suppressed with poorly absorbed oral broad-spectrum antibiotics.

31 porins is instrumental to rationally develop broad-spectrum antibiotics.

32 CI, 30.7%-35.6%) of antimicrobials used were broad-spectrum antibiotics.

33 patients with septic shock warrant emergent broad-spectrum antibiotics.

34 version of Gram-positive-only compounds into broad-spectrum antibiotics.

35 art due to emergence of strains resistant to broad-spectrum antibiotics.

36 tuations as a strategy to reduce exposure to broad-spectrum antibiotics.

37 diversity, even in the presence of systemic broad-spectrum antibiotics.

38 acute sinusitis), 868 (35%) were prescribed broad-spectrum antibiotics.

39 ted with GVHD development and treatment with broad-spectrum antibiotics.

40 ty testing often results in prolonged use of broad-spectrum antibiotics.

41 re infected with VPI 10463 after exposure to broad-spectrum antibiotics.

42 (2) the proportion of antibiotics that were broad-spectrum antibiotics; (3) the proportion of antibi

43 , pretreatment of donors and recipients with broad-spectrum antibiotics (Abx) or use of germ-free (GF

44 Interestingly, WT mice treated with broad-spectrum antibiotics (Abx) were fully protected fr

45 Consistently, long-term dosing of broad-spectrum antibiotics (ABXs) in Rag2(R229Q) mice am

46 Broad-spectrum antibiotics accounted for 26% of use in S

47 -ring scaffold, which is essential for their broad-spectrum antibiotic activities.

48 Peptides with potent broad-spectrum antibiotic activity have been identified

49 compounds identified in the screen exhibited broad-spectrum antibiotic activity, validating trans-tra

50 fampicin (Rif) is one of the most potent and broad spectrum antibiotics against bacterial pathogens a

51 patients with sepsis (i.e., blood cultures, broad-spectrum antibiotic agents, and lactate measuremen

52 Finally, in a small trial, a topical broad-spectrum antibiotic also slowed skin wound healing

53 ave improved infant survival, treatment with broad-spectrum antibiotics alters intestinal microbiota

54 ction of cytopathies and coagulopathies, and broad spectrum antibiotics and antifungal agents.

55 For example, doxycycline is a broad-spectrum antibiotic and kills beneficial bacteria.

56 Broad-spectrum antibiotics and bowel rest were the prima

57 allergies (BLAs) are more likely to receive broad-spectrum antibiotics and experience adverse outcom

58 c allergies (BLA) are more likely to receive broad-spectrum antibiotics and experience adverse outcom

59 agement consists of prompt intervention with broad-spectrum antibiotics and fluid resuscitation, even

60 helicidin antimicrobial peptides that act as broad-spectrum antibiotics and influence the immune defe

61 his concept, we depleted gut microbiota with broad-spectrum antibiotics and performed renal ischemia-

62 as potential for reducing unnecessary use of broad-spectrum antibiotics and promoting more timely pre

63 ID) physicians remotely reviewed patients on broad-spectrum antibiotics and those admitted with lower

64 ID physicians remotely reviewed patients on broad-spectrum antibiotics and those admitted with lower

65 rdship is needed to promote judicious use of broad-spectrum antibiotics and ultimately decrease antib

66 nzymes that provide resistance to a range of broad-spectrum antibiotics) and thioredoxin reductase ge

67 ibitor, compound 1 has the potential to be a broad-spectrum antibiotic, and should be effective again

68 st one antibiotic course, 312 (71%) received broad-spectrum antibiotics, and 61 (14%) received potent

69 ng fasciitis, wide and repeated debridement, broad-spectrum antibiotics, and eventual abdominal wall

70 infectious workup including blood cultures, broad-spectrum antibiotics, and mechanical ventilatory s

71 s study, we show that A153 produces a second broad spectrum antibiotic, andrimid.

72 Broad-spectrum antibiotics are administered to patients

73 Broad-spectrum antibiotics are commonly prescribed for t

74 Broad-spectrum antibiotics are commonly prescribed, but

75 Broad-spectrum antibiotics are frequently prescribed to

76 Due to this extended diagnostic period, broad-spectrum antibiotics are generally prescribed to p

77 ntification is slow and unreliable such that broad-spectrum antibiotics are often used to insure cove

78 Three broad-spectrum antibiotics are reviewed, each from a dif

79 accurate diagnosis of disease is difficult, broad-spectrum antibiotics are routinely used as a gener

80 ing the microbial burden in mutant mice with broad spectrum antibiotics-as well as transplanting gut

81 Repeated exposure to broad-spectrum antibiotics at ages 0 to 23 months is ass

82 Rates of overall antibiotic use and use of broad-spectrum antibiotics (azithromycin and clarithromy

83 moniae is a useful tool for the discovery of broad-spectrum antibiotics because of its genetic mallea

84 In a multivariable analysis, early use of broad-spectrum antibiotics before day 0 (day of transpla

85 that altruistically degrades the widely used broad-spectrum antibiotics beta-lactams (which disrupt c

86 cient - 1.59, p = 0.025) and those receiving broad spectrum antibiotics (broad - 14.5 vs. narrow - 2.

87 econd or third-generation cephalosporin, and broad-spectrum antibiotics (Broad-abx).

88 f mechanical ventilation, and consumption of broad-spectrum antibiotics but not with longer hospital

89 Aminoglycosides are widely used broad-spectrum antibiotics, but they inflict permanent h

90 t animal studies suggest that minocycline, a broad-spectrum antibiotic capable of regulating immune p

91 The first broad-spectrum antibiotic chloramphenicol and one of the

92 ections refractory to treatment with current broad-spectrum antibiotic classes warrants the explorati

93 oth of which were completely suppressed by a broad-spectrum antibiotic cocktail.

94 A similar effect was found for broad-spectrum antibiotics (comprising 10.1% of total an

95 Carbapenems are broad spectrum antibiotics considered as a "last resort"

96 road-spectrum therapy [DBT]) and (2) empiric broad-spectrum antibiotics continued as post-empiric the

97 Suppression of gut microbiome with broad-spectrum antibiotics decreases miR-204, increases

98 Prescription of broad-spectrum antibiotics, defined for this study as qu

99 ne responses and pathology by treatment with broad-spectrum antibiotics definitively links the role o

100 ric narrow-spectrum antibiotics escalated to broad-spectrum antibiotics (delayed broad-spectrum thera

101 talized with pneumonia often receive empiric broad-spectrum antibiotics despite low rates of multidru

102 Broad-spectrum antibiotics disrupt colonisation resistan

103 Prolonged use of broad-spectrum antibiotics disrupts the indigenous gut m

104 AGs) constitute a major family of potent and broad-spectrum antibiotics disturbing protein synthesis

105 At present, broad-spectrum antibiotic drugs are used to treat this d

106 We show that patients exposed to broad-spectrum antibiotics during previous hospitalizati

107 Dimetridazole (DMZ) is a broad-spectrum antibiotic effective against bacterial an

108 Receipt of broad-spectrum antibiotics enhances Candida albicans col

109 hether the change of gut microbiota with the broad spectrum antibiotic enrofloxacin will modulate con

110 Additionally, the impact of a broad-spectrum antibiotic (enrofloxacin) and phage thera

111 d intestinal bacteria as an alternative to a broad-spectrum antibiotic (enrofloxacin) in clinically h

112 mice before SCI (e.g., via oral delivery of broad-spectrum antibiotics) exacerbates neurological imp

113 of antibiotics are rare, structurally novel broad-spectrum antibiotics exceptionally so.

114 ntilation (OR 1.65; 95% CI, 1.50-1.82), late broad-spectrum antibiotic exposure (OR 3.24; 95% CI, 2.9

115 boys, 44 girls), 3 months to 12 yrs old, on broad spectrum antibiotics for at least 48 hrs were rand

116 Doripenem is a valuable broad-spectrum antibiotic for empirical therapy in criti

117 heme diet (0.5 mumol/g heme) with or without broad-spectrum antibiotics for 14 d.

118 C57BL/6 male mice were treated with broad-spectrum antibiotics for 4 weeks to deplete their

119 ar, the selective pressure from prior use of broad-spectrum antibiotics for 5 days or more increased

120 First-line treatments are broad-spectrum antibiotics for acute bacterial prostatit

121 sceptibility results could reduce overuse of broad-spectrum antibiotics for empirical treatment of ba

122 (69.9%) and was associated with prior use of broad-spectrum antibiotics for more than 5 days for trea

123 5, pneumonia practice guidelines recommended broad-spectrum antibiotics for patients with risk factor

124 e found a substantial increase in the use of broad-spectrum antibiotics for pneumonia despite no incr

125 The patient was on broad-spectrum antibiotics for pneumonia including vanco

126 Among 600 patients treated with broad-spectrum antibiotics for possible sepsis, 1 in 3 m

127 Broad-spectrum antibiotics for recurrent multidrug-resis

128 Broad-spectrum antibiotics for suspected early-onset neo

129 at >=36 weeks of gestational age, requiring broad-spectrum antibiotics for treatment of sEONS in the

130 e transferase that confers resistance to the broad-spectrum antibiotic fosfomycin, (1R,2S)-epoxypropy

131 e transferase that confers resistance to the broad-spectrum antibiotic fosfomycin, which contains a p

132 It is the target of the naturally occurring, broad-spectrum antibiotic fosfomycin.

133 zyme in its apo form and in complex with the broad-spectrum antibiotic fosmidomycin solved to 1.5 and

134 robial peptides (AMPs) are highly potent and broad-spectrum antibiotics, found as components of the i

135 Aminoglycosides (AGs) are highly potent, broad-spectrum antibiotics frequently used as first-line

136 Neonatal mice were transiently exposed to broad-spectrum antibiotics from birth for either 3- (SE)

137 organisms increase mortality(3,4) and use of broad-spectrum antibiotics, further selecting for resist

138 Immediate empirical broad-spectrum antibiotics, further tailored based on ti

139 y the case with tropodithietic acid (TDA), a broad-spectrum antibiotic generated by marine bacteria t

140 ystem exploits the toxicity of commonly used broad-spectrum antibiotics geneticin and puromycin to ki

141 Doxycycline, a broad-spectrum antibiotic, has certain antiangiogenic pr

142 dies on vaccination in subjects treated with broad-spectrum antibiotics have provided causal evidence

143 We conclude that prolonged exposure to broad spectrum antibiotics in the neonatal period is ass

144 3rd generation cephalosporins (1st-3rdCE) to broad-spectrum antibiotics in decreasing surgical site i

145 pean EDs in prescriptions of antibiotics and broad-spectrum antibiotics in febrile children.

146 y 31, 2021, including 350 children receiving broad-spectrum antibiotics in the inpatient and outpatie

147 ohort, low-value care was most prevalent for broad-spectrum antibiotics in the treatment of community

148 acute sinusitis), 4307 (14%) were prescribed broad-spectrum antibiotics including amoxicillin-clavula

149 outcomes while minimizing unnecessary use of broad-spectrum antibiotics, including carbapenems.

150 Use of broad-spectrum antibiotics increased across many conditi

151 Use of broad-spectrum antibiotics increased from 24% of all ant

152 However, prescription rates for broad-spectrum antibiotics increased significantly.

153 In human skin wounds, topical broad-spectrum antibiotics inhibit glutamine production

154 rgical management of SSIs, patients received broad-spectrum antibiotics intravenously for 10 days and

155 Dehydrophos (DHP), a broad-spectrum antibiotic, is a phosphonotripeptide prod

156 Ciprofloxacin (CIP) a broad-spectrum antibiotic, is used extensively for the t

157 ex-related prescribing units), the number of broad-spectrum antibiotic items prescribed, and broad-sp

158 ad-spectrum antibiotic items prescribed, and broad-spectrum antibiotic items prescribed, expressed as

159 plications, oral administration of empirical broad-spectrum antibiotics may be an acceptable alternat

160 ow transplantation animals were treated with broad-spectrum antibiotics (metronidazole, ciprofloxacin

161 sed by the gut microbiota, as confirmed by a broad-spectrum antibiotic model.

162 Oral treatment with a broad spectrum antibiotic modifies gut microbiota compos

163 Of patients initially treated with broad-spectrum antibiotics, most were still receiving br

164 Of patients initially treated with broad-spectrum antibiotics, most were still receiving br

165 c patients by enabling rapid deescalation of broad-spectrum antibiotics, multiplex methods offer even

166 creatitis, it is common to administer early, broad-spectrum antibiotics, often a carbapenem, in the h

167 The impact of broad-spectrum antibiotics on antimicrobial resistance a

168 rse consequences of microbiota disruption by broad-spectrum antibiotics on innate immune defense to i

169 uppression of the intestinal microbiota with broad spectrum antibiotics or ablation of TLR4 signaling

170 Accordingly, treatment with broad-spectrum antibiotics or Ab-mediated blockade of IL

171 hus, MscL activators have potential as novel broad-spectrum antibiotics or adjuvants that work with a

172 Sex-matched C57BL/6T mice were administered broad-spectrum antibiotics or vehicle-control from the a

173 t tissue, we tested whether metronidazole (a broad-spectrum antibiotic) or a sulfur-restricted diet r

174 Treatment of mice with broad-spectrum antibiotics, or with the gut-restricted a

175 ese sites, in part through the production of broad-spectrum antibiotic peptides.

176 num with no signs of healing after receiving broad spectrum antibiotics post-surgery.

177 ich mediating pathways, including changes in broad-spectrum antibiotic prescribing and hospital crowd

178 Broad-spectrum antibiotic prescribing decreased from 26.

179 rity of antibiotic exposure in children, and broad-spectrum antibiotic prescribing for acute respirat

180 th a significant reduction in both total and broad-spectrum antibiotic prescribing in primary care in

181 ses, the strongest independent predictors of broad-spectrum antibiotic prescribing were physician spe

182 %-41.6%), and among those prescriptions, the broad-spectrum antibiotic prescription rate was 52.1% (r

183 The broad-spectrum antibiotic prescription relative percenta

184 he most frequent diagnoses co-occurring with broad-spectrum antibiotic prescription, narrowing antibi

185 ription rate for ARTI and a dramatic drop in broad-spectrum antibiotic prescriptions, in favor of amo

186 FMT-randomized patients received 5 days of broad-spectrum antibiotic pretreatment, then a single FM

187 e and often persist despite several weeks of broad-spectrum antibiotics prior to surgery.

188 sruption of the gut microbiota by receipt of broad-spectrum antibiotics prior to treatment with cance

189 Phenazine-1-carboxylic acid (PCA) is a broad-spectrum antibiotic produced by rhizobacteria in t

190 cteria resistance to zwittermicin A, a novel broad-spectrum antibiotic produced by species of Bacillu

191 Streptolydigin is a highly potent, broad-spectrum antibiotic produced by Streptomyces lydic

192 Platensimycin (PTM) is a recently discovered broad-spectrum antibiotic produced by Streptomyces plate

193 Administration of broad-spectrum antibiotics promotes VRE colonization by

194 ugh cathepsin G has previously shown to have broad spectrum antibiotic properties, challenges of mice

195 Broad-spectrum antibiotic prophylaxis is recommended for

196 ficantly pronounced in patients treated with broad-spectrum antibiotics, receiving invasive mechanica

197 Fluoroquinolones (FQs) are broad-spectrum antibiotics recommended for the treatment

198 Broad-spectrum antibiotics reduce bacterial diversity wh

199 Compared with macrolide monotherapy, each broad-spectrum antibiotic regimen was associated with in

200 th risen globally, in part due to increasing broad-spectrum antibiotic resistance.

201 /= 4 episodes); this effect was stronger for broad-spectrum antibiotics (RR, 1.16; 95% CI, 1.06-1.29)

202 .94; I2 = 86); and 17% relative reduction in broad-spectrum antibiotic selection (N = 17 studies, RR

203 hydroxychloroquine, lopinavir/ritonavir, and broad-spectrum antibiotics, she ultimately died from mul

204 Empirical broad-spectrum antibiotics should be administered to any

205 of novel EPSPS inhibitors with potential as broad-spectrum antibiotics should be based on the active

206 aced for symptomatic relief and prophylactic broad-spectrum antibiotics should be given only in the s

207 Broad-spectrum antibiotics should be reserved for early

208 Treatment with broad-spectrum antibiotics substantially reduced colonic

209 inhibitors of this enzyme that could protect broad spectrum antibiotics such as imipenem from hydroly

210 Broad-spectrum antibiotics such as carbapenems increase

211 However, increasing evidence suggests that broad-spectrum antibiotics, such as piperacillin-tazobac

212 monstrates that secreted proteins can act as broad-spectrum antibiotics, suggesting that ABPs represe

213 f intestinal microbiota by administration of broad-spectrum antibiotics suppressed the number of infi

214 ial production of TMAO was inhibited through broad-spectrum antibiotics, targeted inhibition of the g

215 ift the strategy for UTI treatment away from broad-spectrum antibiotics targeting conserved aspects o

216 The broad-spectrum antibiotic tetracycline is used in animal

217 Oxytetracycline (OTC) is a broad-spectrum antibiotic that acts by inhibiting protei

218 Fluopsin C is a broad-spectrum antibiotic that contains a copper ion che

219 CAP is a broad-spectrum antibiotic that has lost its favor due to

220 d-Cycloserine (DCS) is a broad-spectrum antibiotic that inhibits d-alanine ligase

221 Ciprofloxacin is a broad-spectrum antibiotic that is recognized as one of t

222 zinyl-4)methane (taurolidine) is a synthetic broad-spectrum antibiotic that reacts with bacterial cel

223 oxymethyl)pro pane-1,3-diol (DCAP), a potent broad-spectrum antibiotic that reduces the transmembrane

224 Aminoglycosides (AGs) are broad-spectrum antibiotics that are associated with kidn

225 lycosides are mostly known as highly potent, broad-spectrum antibiotics that exert their antibacteria

226 hat limit their use, resulting in the use of broad-spectrum antibiotics that increase the risk for an

227 ed allergy to penicillin leads to the use of broad-spectrum antibiotics that increase the risk for an

228 Aminoglycosides are chemically diverse, broad-spectrum antibiotics that target functional center

229 A broad spectrum antibiotic therapy as empirical treatment

230 He was initially treated with broad spectrum antibiotic therapy including ceftazidime

231 idium difficile infection is associated with broad-spectrum antibiotic therapy and is the most common

232 Early initiation of appropriate broad-spectrum antibiotic therapy must take into conside

233 source of infection (1C); administration of broad-spectrum antibiotic therapy within 1 hr of diagnos

234 ly 10 liters per day in the first 72 hours), broad-spectrum antibiotic therapy, and ventilatory suppo

235 mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by s

236 ieves good outcomes without excessive use of broad-spectrum antibiotic therapy.

237 ), is a dangerous and costly complication of broad-spectrum antibiotic therapy.

238 bacteria and require both source control and broad-spectrum antibiotic therapy.

239 mindful of the potential risks of long-term broad-spectrum antibiotic therapy.

240 ed MAMPs and can be significantly reduced by broad-spectrum antibiotics, thereby affecting susceptibi

241 We have used broad spectrum antibiotics to demonstrate that these con

242 Here, we administered broad-spectrum antibiotics to healthy adults prior and s

243 microbiota into mice that were treated with broad-spectrum antibiotics to suppress their native micr

244 in a randomized trial the effectiveness of a broad spectrum antibiotic treatment in patients with cir

245 Furthermore, broad spectrum antibiotic treatment resolves the infecti

246 omptly randomized to receive a standard or a broad spectrum antibiotic treatment.

247 Furthermore, while broad-spectrum antibiotic treatment (to deplete the inte

248 Further, a broad-spectrum antibiotic treatment delivered before B.

249 ude that microbiome depletion as a result of broad-spectrum antibiotic treatment disrupts basal Stat1

250 f this study was to evaluate whether empiric broad-spectrum antibiotic treatment impacts mortality an

251 theoretical advantages because a decrease in broad-spectrum antibiotic treatment in low-risk patients

252 asionally, skip areas but is associated with broad-spectrum antibiotic treatment or chemotherapy.

253 After adjustment, empiric broad-spectrum antibiotic treatment was not associated w

254 erium Phaeobacter inhibens we found that the broad-spectrum antibiotic tropodithietic acid (TDA) caus

255 Patients are treated with broad spectrum antibiotics until AST results become avai

256 ly treat suspected bacterial infections with broad-spectrum antibiotics until standard culture-based

257 sociated with adverse outcomes and increased broad-spectrum antibiotic usage.

258 Broad-spectrum antibiotic use and, consequently, antibio

259 before and after implementation, the rate of broad-spectrum antibiotic use decreased from 506 days to

260 ding of the detrimental effects conferred by broad-spectrum antibiotic use on the health of the benef

261 Empiric broad-spectrum antibiotic use was not associated with mo

262 Broad-spectrum antibiotic use was reported.

263 patient penicillin allergies results in more broad-spectrum antibiotic use, treatment failures, and a

264 line adherence would unnecessarily stimulate broad-spectrum antibiotic use.

265 LRIs and might contribute to a reduction in broad-spectrum antibiotic use.

266 Chloramphenicol is a broad-spectrum antibiotic used for the treatment of many

267 Chloramphenicol (Cam) is a broad-spectrum antibiotic used to combat bacterial infec

268 Amoxicillin is a broad-spectrum antibiotic used to treat a variety of gra

269 Aminoglycosides (AGs) are broad-spectrum antibiotics used for the treatment of ser

270 nd piperacillin-tazobactam are commonly used broad-spectrum antibiotics used to treat patients with p

271 Compared to the baseline period, broad-spectrum antibiotic utilization decreased by 24.4%

272 Compared to the baseline period, broad-spectrum antibiotic utilization decreased by 24.4%

273 mpiric therapy, the probability of receiving broad-spectrum antibiotics varied as much as 34+ percent

274 events documented by the clinician (3.7% for broad-spectrum antibiotics vs 2.7% for narrow-spectrum a

275 .8%]) and reported by the patient (35.6% for broad-spectrum antibiotics vs 25.1% for narrow-spectrum

276 a lower rate of treatment failure (3.4% for broad-spectrum antibiotics vs 3.1% for narrow-spectrum a

277 rse child quality of life (score of 90.2 for broad-spectrum antibiotics vs 91.5 for narrow-spectrum a

278 Broad-spectrum antibiotics vs narrow-spectrum antibiotic

279 uris-infected IL-10/IL-4-deficient mice if a broad spectrum antibiotic was administered, suggesting t

280 Early exposure to broad-spectrum antibiotics was also associated with obes

281 In mice receiving broad-spectrum antibiotics, we observed reductions in mi

282 Broad-spectrum antibiotics were associated with a slight

283 Broad-spectrum antibiotics were associated with increase

284 adult and 14% of pediatric prescriptions for broad-spectrum antibiotics were for the common cold, uns

285 Broad-spectrum antibiotics were initialized, and minimal

286 ren with acute respiratory tract infections, broad-spectrum antibiotics were not associated with bett

287 Broad-spectrum antibiotics were not effective.

288 es, cancer, use of antibiotics, particularly broad-spectrum antibiotics, were associated with prolong

289 cancer, and use of antibiotics, particularly broad-spectrum antibiotics, were associated with prolong

290 coverage while minimizing unnecessary use of broad-spectrum antibiotics when managing sepsis.

291 a new chemical scaffold for developing novel broad-spectrum antibiotics which can help replenish the

292 global health burden currently treated with broad-spectrum antibiotics which disrupt commensal bacte

293 Management of infected trees includes use of broad-spectrum antibiotics, which have disadvantages.

294 irulence factors can provide access to novel broad-spectrum antibiotics, which may serve as important

295 Aminoglycosides are broad-spectrum antibiotics whose mechanism of action is

296 Fluoroquinolones (FQ) are powerful broad-spectrum antibiotics whose side effects include re

297 Rifaximin, an oral, non-systemic, broad-spectrum antibiotic with a favorable safety profil

298 nt placement, endoscopic sphincterotomy, and broad-spectrum antibiotics with rapid closure of the fis

299 The development of novel broad-spectrum antibiotics, with efficacy against both g

300 ion (Scvo2) monitoring within 2 hrs; b) give broad-spectrum antibiotics within 4 hrs; c) complete ear